is all in $AAPL $TSLA and $PMCB
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
12 Milestones for 2017
1-3. Generate revenue via worldwide psoriasis cream sales, posting sales figures for Q2, Q3, and Q4.
4. Seek fast-track approval for testing cream on other skin ailments, such as eczema, rosacea, seborrheic dermatitis, and acne (?). With safety testing already completed on the formulation for psoriasis, approval for testing for other skin conditions should be expeditious. Approval for alternate use trials by Q3 seems plausible to me.
5. With money coming in from cream sales, have OWCP retain a top IP law firm such as Ropes & Gray or MoFo to assist with patent protection and licensing agreements.
6. Secure additional financing to accelerate the pace of sublingual treatment trials. With revenue coming in, secure a line of credit or seek an investment from a private equity firm. Just like having Emilia Cosmetics and Medmar putting up $300,000 each was a vote of confidence in OWCP, having JPM issue a $10 Million line of credit or having a private equity firm like Apollo taking a small stake would put OWCP in league with big board biotech companies.
7. Uplist. Once OWCP is trading steadily over $1, seek counsel to uplist.
8. License sublingual tablet to other biotech companies. Success begets success. Once OWCP is better known, expect companies to come out of the woodworks and pay licensing fees for the sublingual tablet. With each successful deal inked, a press release of “Company X is please to announce it has entered into an agreement with OWC Pharmaceuticals to license OWCP’s sublingual tablet technology, which Company X will use in clinical studies for it’s trails of XYZ to treat [disease]. Company X CEO blah blah said, “We are so excited to license OWCP’s delivery mechanisms as it allows very precise control of dosing. Inhaling cannabis in a doctors office is crude and unscientific…” will be a monthly occurrence.
9. Gain approval for multiple myeloma trials in humans.
10. Gain approval for study of formulation to treat fibromyalgia in humans.
11. Gain approval for study of formulation to treat PTSD in humans.
12. Gain approval for study of formulation to treat migraine in humans.
So there you have it, a very plausible list of 12 hammers that OWCP can easily drop in 2017. I’m having fun imagining what each and every one will do to our share price!
Go $OWCP!
120,000 at average price of 0.407
Sure, what are you comparing OWCP too? MCig? Apples and oranges.
Look at TSRO. It's a typical big board biotech company that has raised and burns through millions of dollars, yet has a value of $7 Billion.
Perhaps OWCP should have listed on the NYSE, maybe they even tried. But years ago no one in their right mind would have underwritten millions for a MMJ company.
That's the other thing you might be over looking. OWCP is YEARS ahead of the competition in research.
OWCP could get snatched up in a heartbeat by a company like Teva. OWCP has patents covering a sublingual tablet for CBD/THC medicines. They will license that to other companies and that will generate millions of dollars of revenue every quarter. And unlike medicines which eventually go generic, OWCPs delivery platform patentS (cream, sublingual tablet, nasal spray) will derive revenue forever.
https://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=11702760
Michelpro has warrants for 761,538 shares (24 months) at $0.25 and another 761,538 shares (36 months) at $0.40.
In the future Michelpro will exercise those warrants and the shares outstanding will increase from 139,255,474 as of Dec 30, 2016 to 140,778,550. Dilution of 1%.
A typical penny stock would have issued 100,000,000 more shares with 200,000,000 in warrants to raise enough capital to manufacture and distribute the product in house. IMHO that's a mistake. Instead, OWCP is letting 2 companies that are already in the business of manufacturing and distributing products to do so for a share of profits and for these warrants. To me that is a sign of the intelligence and foresight of the executives. They are moving the company forward with minimal impact on existing shareholders.
Happy to have missed my prediction of .62!
God I miss my Bloomberg terminal. Which market data system do you use?
I loath making short term predictions, but I'm thinking .62 today.
Yes, pot has no calming effect whatsoever so why on earth would it calm skin conditions like psoriasis, eczema, poison ivy, goodness knows what else.
Well from my experience with venture capitalists, the terms of investment are very favorable for the capitalists and less so for the executives. Who really gets killed in the long run is the shareholders.
The VC people come in, tell the owners they're all gonna be multimillionaires and just get them to sign absurd terms.
In OWCP, I see a very careful and cautious advancement, nearly to a fault. I see owners who want to do right by their shareholders and who don't want to give up a large stake of their company. They know what they have and they are likely well off enough or comfortable enough financially that they retain their holdings and control.
There's nothing wrong with flippers. I myself was in arbitrage for a few years. It takes a boatload of money and broker-dealer status to make money like that, but it is essentially risk free.
A small problem for me as an investor today is that I still have that instinct to take profits and cut losses immediately. Being 3+ years long on OWCP is a no brainer, however, if you've taken the time and done the due diligence. I've not parted with a single share and can't imagine selling any in 2017.
People have this simplified view of the stock market where every transaction is a buyer and a seller agreeing on a price. The truth is market makers buy from the seller and sell to the buyer, so they make money on each transaction twice. Additionally, MMs can do naked shorts and post absurd bid/asks to make it look like pressure is building one way or another.
The volatility in this stock is purely MMs pushing it up and down to make money. Once earnings are in an we get a realistic PPS the games will be over and we'll see some stability. But it's going to a an exciting ride. OWCP has so many fires in the forge. There's going to be exciting news every few months for the foreseeable future.
LOL I'm the only one giving her any DD
Yup, wife just gave me the green light to put in another 10K.
Yup, once someone comes out with a PPS estimate the stock will be added to buy programs and the MMs won't be able to swing the price up and down. Price stability is coming as soon as we are a generating revenue.
The MMs see the writing on the wall and are making as much money as possible while they can.
I used to be a MM and looking at the chart the last 2 days it was clear the MMs were setting up a Bear Trap for today. Day traders are very predictable and the MMs will always beat the day traders.
Go $OWCP Long and Strong.
Just snagged another 10K at .50. Love this stock!
Excellent, insightful post.
If I could add two things: market makers have access to Level 3 market data and the designated MM gets company news before the markets. That's right, the company has to give the designated MM a heads-up before any public announcement. This is so the MM can prepare for the markets reaction, but it essentially means they get start the day with inside info.
In my experience, the pre-market info the designated MM gets spreads fairly quickly as the MMs all know each other well. So just like the casinos where the house always wins in the long run, in the markets the MMs always win in the long run.
Revenues, once started, will be dramatic. OWCP is coasting right now, but very soon it will be bringing in money on two fronts. First up is the psoriasis cream, which will be marked in EU and in certain US states. If you read the deals, they show just how savvy the OWCP executive team is. For a share of the profits, the two companies will manufacture, distribute and market the product. It is a genius strategy, and both companies put up $300,000 each for right to be the distributer. If that isn't a total vote of confidence, I don't know what is.
Next is the sublingual tablet. Take a look at the Oct 2016 press release (my bold/underline):
https://www.otcmarkets.com/stock/OWCP/news/OWC-Pharmaceutical-Research-Corp-Completes-Development-of-Its-Medical-Cannabis-Sublingual-Tablet?id=142876&b=y
Anyone know if Puma is the designated MM for OWCP?
Wow what a ride! For those Bulls out there having doubts, take a close look at the intraday chart, specifically the volume when the stock reaches the lows. Market Makers are triggering stop loss orders (people are very predictable, playing stop loss orders at nice round numbers like $0.50) and otherwise scaring people into selling. Looks like the MMs will have a big surprise for us tomorrow too.
If you wondering what's going on, take a long hard look at how MMs moved $AXIM. MMs work in an Industry, so the very same MMs who manipulated the hell out of AXIM are doing the same thing here. Check out the AXIM chart 1/17 and 1/18. News hit on the 19th, but look at the swings over the 17th and 18th.
https://www.otcmarkets.com/stock/OWCP/chart
Exactly. We know it works because of where it is in the approval process. Once it's for sale in Europe and in the US in MMJ states, I fully expect to see the cream being sold on ebay and craigslist to those in states without MMJ. Gonna be a real money maker.
I mean, look at the contract they signed. The manufacturer is paying for everything and gave OWCP $300,000 cash! They know it's a homerun.
A typical penny stock would have issued another 50,000,000 shares to try to raise the money to manufacture and market the cream themselves. Wrong! Let another company do all that work for 25% of profits. It's genius. Seriously, just about every business decision OWCP has made has been brilliant.
Dr Baruch has 10+ in Israel's health ministry, so I'd imagine he has a decent pension. They clearly don't want to dilute shares over the years to pay themselves. Can't for the life of me understand why you view that as a red flag. Mark my words, once revenue comes in starting Q2-Q3 the executive pay will see a well deserved bump.
As for the Jeffrey guy, who knows if he even has a contract. But he is a member of the "Advisors Board", not the board of directors and he is not an executive of the company. I'll send an email to OWC asking about that old FCC stuff and see what the response is. I would not be surprised at all if Jeffrey approached OWC. Seriously doubt it was the other way around.
So funny because I joking told my wife the other day that cannabis may actually be the biblical tree of life!
I'm still trying to decide if OWCP is Biotech or Pharma, or both.
Average Pharma PE ratios are in the 180s, but Biotech is 321.
http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/pedata.html
I think Forward PE number is more rational to use, those are 21 for pharma and 110 for biotech.
Oh, so you like to invest in those stocks with a billion shares outstanding with another billion in warrants so the executives can pay themselves $250,000 a year?
How's that investment strategy going for you?
OWCP has no toxic financing. I believe they will up their pay, and rightfully so, once they generate profits in Q2.
So the "red flags" you've found are low executive pay and a guy in the advisory board who was overzealous 10 years ago? Humm, i think i'll stay long at .20.
MMs are broker-dealers and are exempt from capital gains and other trading restriction laws. Plus they can see level 3 data.
Is this real? OMG US pharma companies would be free to acquire OWCP and other pipe-line MMJ cos!
True story: friend invested about $20K in penny stocks and one went to $15. Gave notice, moved to TX and waited out the year so he didn't have to pay capital gains nor state income tax. Was 32. Hasn't "worked" a day since.
Actually, if you've read about other companies' research you have to wonder if some of the Canadian companies are inadvertently infringing on OWCP's delivery method patents.
If that were the case, once OWCP has revenues from the psoriasis cream they could start legal actions and force infringing companies to license their tech or halt research.
NOT saying this is happening, just saying it's plausible. Israel discovered THC, they are years ahead of the Canadians.
Again, this is not DD, just pure speculation on my part. It does, however, make you realize that OWCP has more potential revenue streams than all the other MMJ companies out there.
Mods, the page is very long and busy. Ideally info is presented in page views with links.
I'd post that lovely 2016 annual report at the top and put everything else into links.
New eyes should see the report first, not the old powerpoint.
Just a suggestion.
Man I feel so bad for people scared into selling today. When revenue starts pouring in and the development engine starts firing on all pistons, this thing will blow up to $7+. In 3-5 years this thing could be $70 if the clinical trials for the anti-cancer sublingual tablet go well. Not to mention licensing fees of the sublingual technology to other pharma companies.
Old school doctors don't want their patients smoking weed! A sublingual tablet that dissolves under the tongue, delivering a precise dosage right to the blood system will be a preferred delivery method for a host of groundbreaking meds. $OWCP has so many future avenues of revenue, even if only one of the 8 patents was successful it would be valued the same as GWPH. Clinical trials are failed when the drug under testing does harm. We all know CBD isn't harmful, so several of their patents will likely ultimately generate revenue.
Just IMHO, of course, do your own DD. But I, for one, would need therapy for the rest of my life if I sold a stock for 70 measly cents and then saw it at $7.
My advice: if you sell for under $7, never, ever lookup the price in the future. It will haunt you.
I'm in starting at .20 and I don't care if it takes 3 years I'm not selling a single share until it's at least $20.
Watching $OWCP the last two days is great practice for what's to come. Many of the long term holders here have a significant stake. If the swings today are thrilling, imagine what it's going to be like when we trade up in dollar land. Look at AXIM's chart, it's down $5 one day, but up $3 the next. It's going to take nerves of steel to not be scared out of our $OWCP shares by MMs once we are in dollar land.
Those of you who already hold 1+ Million shares are experiencing this I'm sure.
I strongly encourage anyone with a significant stake to research how Market Makers herd stocks up and down, making money each way. There are some great youtube videos on the subject.
Once you understand what's happening and why, it takes the fear out of the dips.
Go $OWCP!
$OWCP and $OMHE are apples and oranges. I own both, but OWCP is biotech where PE ratios are over 300 and OMHE is in retail where PEs are around 30.
Good, then my friends can load up on even more shares.
MM's are accumulating shares before the stock rises again tomorrow. OWCP will be in play all week. Remember, MMs provide liquidity and in return they make $ on volume and they make $$$ on volatility. Where there is volatility and volume the bid/ask widens and they make even more money.
It's going to be a bumpy ride to the top, but understand that it's indicative of a very healthy market. MMs and day traders need to make money too.
Let's all get rich together on $OWCP. There is no wrong way to trade as long as you're making money! GLTA tomorrow!
How Drugs are Developed and Approved from the FDA website. Interesting background info to have on our $OWCP investment.
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/default.htm
Pretty sure I recall the CEO saying recently they wanted to uplist to NASDAQ, so I doubt they would want to massively dilute the number of outstanding shares as it would drive the price down and they can't uplist until after the stock is trading above US $1.00.
If any new traders are wondering what causes stocks to fluctuate intra-day, I suggest looking into videos or blogs on Market Makers' Accumulation processes.
This video shows you, for example, how the MMs can herd traders exactly like big fish in the oceans herd smaller fish. Once you are aware of the fact that MMs do this to make money all day long you'll better understand that some of the moves we endure are just MMs trying to manipulate people into selling.
Someone posted "see you at .20" today, right. So you see that comment and it's in the back of your head and your way up from .95 anyway and you go ahead and sell some at .70 because why not it's moving down, I'm locking up profits.
In reality the MMs are just driven to any stocks that have high volume.
Love the 0.6999 closing price.
(check out my username lol)
You realize the average PE ratio of an established biotech stock is over 300? Once $OWCP does post revenue for the psoriasis cream (which btw they are now going to initiate clinical trials for other skin disorders) the stock will snap way up.